23
Participants
Start Date
March 31, 2004
Primary Completion Date
November 30, 2005
Study Completion Date
November 30, 2005
activated recombinant human factor VII
Novo Nordisk Investigational Site, Sofia
Novo Nordisk Investigational Site, Johannesburg
Novo Nordisk Investigational Site, New Hyde Park
Novo Nordisk Investigational Site, Philadelphia
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Bornova-IZMIR
Novo Nordisk Investigational Site, Capa-ISTANBUL
Novo Nordisk Investigational Site, Santander
Novo Nordisk Investigational Site, Seville
Novo Nordisk Investigational Site, Indianapolis
Novo Nordisk Investigational Site, Detroit
Novo Nordisk Investigational Site, Iowa City
Novo Nordisk Investigational Site, Lille
Novo Nordisk Investigational Site, Chicago
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Houston
Novo Nordisk Investigational Site, Los Angeles
Novo Nordisk Investigational Site, Le Kremlin-Bicêtre
Novo Nordisk Investigational Site, Berkeley
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Timișoara
Novo Nordisk Investigational Site, Campinas
Novo Nordisk Investigational Site, New Orleans
Novo Nordisk Investigational Site, Boston
Novo Nordisk Investigational Site, Newark
Novo Nordisk Investigational Site, Philadelphia
Novo Nordisk Investigational Site, Ciudad Autónoma de Bs. As.
Novo Nordisk Investigational Site, Rio de Janeiro
Novo Nordisk Investigational Site, Belo Horizonte
Novo Nordisk Investigational Site, Recife
Novo Nordisk Investigational Site, Ribeirão Preto
Novo Nordisk Investigational Site, Manila
Novo Nordisk Investigational Site, Gdansk
Novo Nordisk Investigational Site, Lublin
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Bucharest
Lead Sponsor
Novo Nordisk A/S
INDUSTRY